Pharma Stock Called "High-Risk Investment"

Merck and Johnson & Johnson are the two worst Dow stocks at midday

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

MIDDAY MARKET CHECK     6/26/2019
Turn $1,000 into $1.57 Million - with "Holy Grail of Medicine" On September 10, 2018, a tiny biotech firm won a patent on a new treatment that can "Cut & Paste" any disease from your body. The Nobel Prize Committee called it "The Holy Grail of Medicine." This under-the-radar company is not yet a household name. Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>
Dow Pares Gains as Big-Cap Pharma Stocks Struggle By Karee Venema Share On The Dow Jones Industrial Average (DJI) jumped triple digits out of the gate on upbeat trade comments from U.S. Treasury Secretary Steven Mnuchin, but has since pared these gains on headwinds from pharma stocks Merck (MRK) and Johnson & Johnson (JNJ). The Dow is still above water, while the S&P 500 Index (SPX) and Nasdaq Composite (IXIC) are modestly higher, too, with the latter two indexes set to snap their three-day losing streak thanks to strong Micron (MU) earnings. Continue reading for more on today's market, including:  How options traders are playing an eBay stock breakout. Why LifeSci Capital called this pharma stock a "high-risk investment." Plus, AbbVie options pop again; new Nasdaq stock continues hot streak; and sinking GBT tests support. >> Continue reading...
LATEST HEADLINES
>> Best Stocks to Buy Before July One pharma stock has ended July higher 100% of the time in the past 10 years >> Call Traders Jump on eBay Stock's Breakout There's been upside call buying on EBAY >> Micron Stock Surges on Earnings Beat MU is pacing for its best day in years >> Wayfair Stock Bounces Back from Walkout Drama Wayfair stock may be ripe for a short squeeze >> Bearish Analysts Bombard Battered Pharma Stock The shares suffered their worst day in years on Wednesday ADVERTISEMENT The #1 Biotech Stock to Own Today On September 10, 2018, a tiny biotech firm won a patent on a new treatment that can "Cut & Paste" any disease from your body. The Nobel Prize Committee called it "The Holy Grail of Medicine." This under-the-radar company is not yet a household name. Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>
To ensure delivery of Schaeffer's Midday Market Check, add us to your contacts! For more information, please visit this link for further instructions. This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Midday Market Check or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Midday Market Check? You can unsubscribe here. For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions. Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:
		SCHAEFFER'S MIDDAY MARKET CHECK enews@schaeffer.com 5151 Pfeiffer Rd. Suite 250 Cincinnati, OH, 45242 USA 800-448-2080 www.schaeffersresearch.com